XGN Exagen: Bozor kapitallashuvining balans qiymatiga nisbati

Exagen (XGN) kompaniyasining rasmiy ramzlari

Ushbu grafikda ko'rsatilgan Exagen Inc. (XGN) bozor narxi sug'urta kompaniyalari tomonidan murakkab testlar uchun to'lovlar amalga oshirilmasligi xavflarini va tartibga soluvchi to'siqlarni hisobga oladi, bunda ko'rsatkich 15.56 darajasida turibdi. Operatsion faoliyat avtomatlashtirilgan tahlil tizimlaridan intensiv foydalanishga va uskunalar ustidan qat'iy texnik nazoratga tayanadi. Yurak va immunitet patologiyalarini tashxislash uchun mo'ljallangan patentlangan AI yechimlari yuqori marjalarni ta'minlab, kengayish uchun kuchli vosita yaratmoqda.

exagen.com (XGN): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 28.10.2026gacha
Exagen Inc. asosiy tovari

Exagen Inc. kompaniyasida diagnostika laboratoriyalarining yuqori darajada ishlatilishi va uskunalarning yeyilishini qat'iy nazorat qilish biznesning moddiy bazasini tashkil etadi, bu esa kompaniyaning narxning buki koeffitsiyentida (price-to-book ratio) aks etgan. Ushbu ko'rsatkich joriy aksiya narxini sof aktivlar bilan solishtiradi, bu esa investorlarga texnologik salohiyat uchun bozor premiumini aniqlash va moddiy aktivlarga nisbatan haddan tashqari to'lov miqdorini baholash imkonini beradi.

Asosiy raqobatchilar

A (Agilent Technologies) - Bozor qiymatining balans qiymatiga nisbati|questdiagnostics.com (DGX) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ILMN (Illumina)|Bozor qiymatining balans qiymatiga koeffitsiyenti Exact Sciences Corp|Bozor kapitallashuvining balans qiymatiga nisbati PerkinElmer RVTY|Kapitallashuvning balans qiymatiga nisbati Bio-Rad Corp (BIO)|Bozor kapitallashuvining balans qiymatiga nisbati NNNN (Anbio Biotechnology)|soterahealth.com - Bozor kapitallashuvining balans qiymatiga nisbati|QuidelOrtho Corporation (QDEL) - Bozor qiymatining balans qiymatiga nisbati|OPK - Kapitallashuvning balans qiymatiga nisbati|CDNA: Bozor kapitallashuvining balans qiymatiga nisbati|MRVI (Maravai) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Fulgent Genetics, Inc.|Bozor qiymatining balans qiymatiga nisbati fluidigm.com (LAB)|Cytek Biosciences - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti OSUR (OraSure Technologies, Inc.)|Bozor qiymatining balans qiymatiga nisbati MDXH|Balans qiymatiga nisbatan bozor kapitallashuvi Lucid Diagnostics, Inc LUCD|Bozor kapitallashuvining balans qiymatiga nisbati PRE (Prenetics Global Ltd)|IMDX: Balans qiymatiga nisbatan bozor kapitallashuvi|trinitybiotech.com - Bozor qiymatining balans qiymatiga nisbati|ProPhase Labs Inc (PRPH) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati AIMD (Ainos Corp)|Bozor qiymatining balans qiymatiga koeffitsiyenti CoDx (CODX)|Kapitallashuvning sof aktivlarga nisbati Heart Test Laboratories HSCS|Kapitallashuvning balans qiymatiga nisbati biomerica.com (BMRA)|Bozor kapitallashuvining balans qiymatiga nisbati CDIO (Cardio Diagnostics Holdings)|Bozor kapitallashuvining balans qiymatiga nisbati Virax Biolabs Group Limited VRAX|Bozor kapitallashuvining balans qiymatiga nisbati BJDX|AWH - Bozor qiymatining xususiy kapitalga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati AXDX|CNTG (CENTOGENE) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Enzo Biochem Inc. (ENZ)|Kapitallashuvning balans qiymatiga nisbati Fresh2 (FRES)|Genetic Technologies (GENE) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati 23andMe Inc (ME)|Bozor kapitallashuvining balans qiymatiga nisbati PMD